Green Light Committee for the WHO European Region (GLC/Europe)

The Green Light Committee for the WHO European Region (GLC/Europe) was established to address the need for scaling up the programmatic management of drug-resistant tuberculosis in the Region.

GLC/Europe functions as a technical support group to WHO/Europe, Member States of the Region, donor agencies and partners. WHO/Europe hosts the GLC/Europe Secretariat.

Members of GLC/Europe 2017-2020

WHO/Europe establishes Green Light Committee
10-06-2011

Call for applications: “The Green Light Committee for the WHO European Region", 2011-2013
14-04-2011

Regional Green Light Committee for the WHO European Region face-to-face meeting and workshop with high drug-resistant tuberculosis burden countries: programmatic aspects of the implementation of new tuberculosis drugs and regimens (2018)

Uptake of current WHO policies on treatment and care for multidrug-resistant tuberculosis (MDR-TB) through the lens of early experience with the introduction of new drugs and shorter regimens in implementing countries

Regional Green Light Committee for the WHO European Region workshop and face-to-face meeting (2017)

Introduction of new medicines for the treatment of drug-resistant tuberculosis in the WHO European Region